Evaluation of Tumour Necrosis Factor Alpha (TNFα) Blockers in Early Rheumatoid Arthritis in France | MicrobiomeTrials← Back to trialsNCT02927509
Evaluation of Tumour Necrosis Factor Alpha (TNFα) Blockers in Early Rheumatoid Arthritis in France
CompletedOBSERVATIONAL
Trial Details
Start: 2016-02-01Est. Completion: 2017-12-31
Enrollment target: 813 participants Other microbiome trials you might be interested in
Rheumatoid Arthritis
The study is designed to learn more about the causes of rheumatoid arthritis (RA). People who get RA have elevated prote…
Aurora, United StatesCompleted Jan 14, 2026
Rheumatoid Arthritis
Aim: To describe 1) The use of TNF blockers monotherapy in early arthritis in daily clinical practice in France 2) To ev…
Nîmes, FranceCompleted Dec 31, 2017
Healthy VolunteerSjogren's SyndromeSalivary Gland Disease
Background:
\- Salivary glands in and around the mouth and throat make saliva. Salivary gland disorders can affect a pe…
Bethesda, United StatesEst. completion Apr 1, 2032